Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

Abizaid, Alexandre; Kedev Sasko; Kedhi, Elvin; Talwar, Suneel; Erglis, Andrejs; Hlinomaz, Ota; Masotti, Monica; Fath-Ordoubadi, Farzin; Lemos, Pedro A; Milewski, Krzysztof; Botelho, Roberto; Costa, Ricardo; Bangalore, Sripal

doi:10.4244/EIJ-D-18-00762

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Date Issued

2018-12-07

Author(s)

Abizaid, Alexandre

Kedhi, Elvin

Talwar, Suneel

Erglis, Andrejs

Hlinomaz, Ota

Masotti, Monica

Fath-Ordoubadi, Farzin

Lemos, Pedro A

Milewski, Krzysztof

Botelho, Roberto

Costa, Ricardo

Bangalore, Sripal

DOI

10.4244/EIJ-D-18-00762

Abstract

The aim of this study was to evaluate the safety and efficacy of the BioMime sirolimus-eluting coronary stent (SES) compared to the XIENCE family of everolimus-eluting coronary stents (EES) in the treatment of patients with de novo native coronary artery lesions.